|
Apr 16
|
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
|
|
Apr 9
|
Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
|
|
Apr 9
|
Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S
|
|
Oct 9
|
Should Value Investors Buy Bavarian Nordic (BVNRY) Stock?
|
|
Jul 26
|
Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval
|
|
Jul 26
|
Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine
|
|
May 21
|
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
|
|
May 21
|
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic
|
|
Dec 13
|
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
|
|
Nov 30
|
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
|
|
Nov 30
|
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
|